Sure, I'd be glad to.
As you would imagine, the Canadian Institutes of Health Research holds the federal mandate for ensuring that health research across the country is occurring and is supported in an effective way so that it is meeting the needs of Canadians. In particular, in the context of autism, CIHR is engaged in both basic scientific research as well as applied scientific research. So their research agenda is to elaborate on autism spectrum disorders, better understand how the health care system is responding, and also, of course, to support basic science to understand causes and treatments for autism. You'll find that at CIHR.
In the context of the Public Health Agency of Canada, our role is in the area of surveillance. So we are very focused on working with stakeholders to develop a world-class surveillance program for autism spectrum disorders.
From the perspective of Health Canada, Health Canada is concerned about the overall health policy and health care policy in the country and working with provinces and territories in that regard.
I'll just come back to the Public Health Agency of Canada for a moment, picking up on what Mr. Lake has just indicated with stakeholders—and by stakeholders, I put first and foremost the families and organizations that are representing families with children who have autism spectrum disorders. That interaction is of extreme importance to us. We will judge the value of our surveillance program on the feedback we receive from those who use that information in designing programs, in accessing programs, and in determining what the needs are going forward for families with autism spectrum disorders.